IP Group's Bramble Energy, First Light Fusion complete funding rounds
14th Feb 2022 07:36
(Sharecast News) - IP Group said its portfolio company Bramble Energy had completed a £35m funding round to further develop and commercialise its fuel cell stack capabilities.
Read moreIP Group flags strong profits after 'highly successful' year
13th Jan 2022 09:19
(Sharecast News) - Intellectual property investor and developer IP Group reported a "highly successful" 2021 in a trading update on Thursday, indicating that it now expected profit to be higher than £425m.
Read moreIP Group reports unrealised gain after one of its holdings completes funding round
29th Nov 2021 08:00
(Sharecast News) - IP Group recorded a large gain on the value of one of the largest companies in its portfolio following a funding round.
Read moreIP Group portfolio company inks joint development agreement with Ceres Power
11th Nov 2021 09:18
(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company RFC Power, a long-duration energy storage company, had signed a joint development agreement with fuel cell technology firm Ceres Power.
Read moreIP Group records £27.5m value gain after recent funding round
25th Oct 2021 08:42
(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portfolio company in its top 20 most valuable holdings, it recorded a net realised and unrealised fair value gain of about £27.5m, or 2.6p per share.
Read moreBoehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology
19th Oct 2021 09:18
(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.
Read moreIP Group CEO, CIO step down after Oxford Nanopore IPO
6th Oct 2021 09:26
(Sharecast News) - IP Group said on Wednesday that chief executive Alan Aubrey and chief investment officer Mike Townend are retiring and stepping down from the board with immediate effect following the successful flotation of its largest holding, Oxford Nanopore Technologies.
Read moreShares soar as Oxford Nanopore makes its London debut
30th Sep 2021 10:42
(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Thursday after the British biotech made its £3.4bn debut on the London Stock Exchange.
Read moreIP Group portfolio company confirms IPO intentions, inks MOU with Oracle
16th Sep 2021 09:08
(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company Oxford Nanopore Technologies had confirmed its intention to proceed with an initial public offering and the signing of a strategic memorandum of understanding and a cornerstone investment agreement with Oracle Corporation.
Read moreSunday share tips: Ceres Power, Dunelm
12th Sep 2021 15:31
(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of IP Group due to their valuation, even as she touted the many "gems" to be found in its portfolio.
Read moreIP Group launches share buyback as interim profits surge
5th Aug 2021 08:49
(Sharecast News) - Intellectual property-based business developer IP Group said on Thursday that it will launch a £20.0m share buyback after witnessing a rise in interim profits.
Read moreIP Group portfolio company completes Series C financing
27th Jul 2021 09:18
(Sharecast News) - Intellectual property-based business investor IP Group said on Tuesday that portfolio company Artios Pharma had completed a $153.0m Series C financing to fund the further development of its clinical-stage pipeline.
Read moreIP Group portfolio business raises $145m in financing round
17th Jun 2021 07:40
(Sharecast News) - Intellectual property business IP Group said on Thursday that portfolio company Apollo Therapeutics had completed a $145.0m financing round.
Read moreIP Group preparing for first divi as portfolio progress continues
9th Jun 2021 08:01
(Sharecast News) - Intellectual property business developer IP Group said on Wednesday that for the year to date, its positive progress made by many of its portfolio companies in 2020 had continued.
Read moreIP Group portfolio co Iksuda raises £42m to develop cancer drug
7th Jun 2021 07:25
(Sharecast News) - Intellectual property business developer IP Group said its portfolio company Iksuda Therapeutics had completed a $42m (£29m) financing round to fund human clinical trials of its lead cancer drug.
Read more